Richert, I.; Chalus, L.; Pinteur, B.; Bravetti, P.; Tortorelli, C.; Alzeeb, G.; Ghiringhelli, F.
Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity. Cells 2026, 15, 741.
https://doi.org/10.3390/cells15090741
AMA Style
Richert I, Chalus L, Pinteur B, Bravetti P, Tortorelli C, Alzeeb G, Ghiringhelli F.
Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity. Cells. 2026; 15(9):741.
https://doi.org/10.3390/cells15090741
Chicago/Turabian Style
Richert, Iseulys, Lionel Chalus, Benoit Pinteur, Paul Bravetti, Corinne Tortorelli, George Alzeeb, and François Ghiringhelli.
2026. "Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity" Cells 15, no. 9: 741.
https://doi.org/10.3390/cells15090741
APA Style
Richert, I., Chalus, L., Pinteur, B., Bravetti, P., Tortorelli, C., Alzeeb, G., & Ghiringhelli, F.
(2026). Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity. Cells, 15(9), 741.
https://doi.org/10.3390/cells15090741